Theravance Biopharma TBPH Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's operating lease ROU assets?
- Theravance Biopharma (TBPH) reported operating lease ROU assets of $23M in Q1 2026.
- How has Theravance Biopharma's operating lease ROU assets changed year-over-year?
- Theravance Biopharma's operating lease ROU assets decreased by 16.1% year-over-year, from $27.43M to $23M.
- What is the long-term trend for Theravance Biopharma's operating lease ROU assets?
- Over 5 years (2020 to 2025), Theravance Biopharma's operating lease ROU assets has grown at a -10.8% compound annual growth rate (CAGR), from $43.26M to $24.37M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.